We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nicox SA | TG:NXOA | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | 0 | EUR |
Date | Time | Source | Headline |
---|---|---|---|
04/12/2024 | 06:30 | UKREG | Nicox annonce la première vente commerciale de ZERVIATE en Chine par son.. |
04/12/2024 | 06:30 | UKREG | Nicox Announces First Commercial Sale of ZERVIATE in China by Partner.. |
02/12/2024 | 06:30 | UKREG | Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans.. |
02/12/2024 | 06:30 | UKREG | Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier.. |
19/11/2024 | 06:30 | UKREG | Nicox annonce la publication de la partie adaptive de l’étude clinique de.. |
19/11/2024 | 06:30 | UKREG | Nicox Announces Publication of the Adaptive Design Period of the NCX 470.. |
17/10/2024 | 05:30 | UKREG | Nicox : Point financier sur le troisième trimestre 2024 et résultats.. |
17/10/2024 | 05:30 | UKREG | Nicox Provides Third Quarter 2024 update and First Half 2024 Financial.. |
14/10/2024 | 05:30 | UKREG | Nicox et Soleus signent un accord de financement de 16,5 millions de.. |
14/10/2024 | 05:30 | UKREG | Nicox and Soleus Sign $16.5 million Royalty and Equity Financing |
Nicox (NXOA) Share Charts1 Year Nicox Chart |
|
1 Month Nicox Chart |
Intraday Nicox Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions